NCT04048278View on ClinicalTrials.gov

Lidocaine Infusion in Pancreatic Cancer

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

November 8, 2018

Primary Completion Date

November 8, 2025

Study Completion Date

January 1, 2026

Conditions
Pancreatic Cancer
Interventions
DRUG

Lidocaine Hydrochloride

IV Lidocaine a 1.0 - 1.5 mg/kg loading infusion for perioperative pain control

DRUG

Saline Solution for Injection

IV Saline a 1.0 - 1.5 mg/kg loading infusion for perioperative pain control

Trial Locations (1)

60612

RECRUITING

University of Illnois at Chicago, Chicago

All Listed Sponsors
lead

University of Illinois at Chicago

OTHER